Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Almirall ( (ES:ALM) ) has shared an update.
Almirall’s Board of Directors has re-elected key members to its leadership and committees following its Ordinary General Meeting. This includes the re-election of Carlos Gallardo Piqué as Chairman and CEO, along with other strategic appointments, which are expected to strengthen the company’s governance and operational continuity. Additionally, the company announced a capital increase to support its flexible dividend system, indicating a commitment to shareholder returns and financial stability.
More about Almirall
Almirall is a pharmaceutical company that operates in the healthcare industry, focusing primarily on dermatology products and services. The company is dedicated to providing innovative medical solutions and has a significant market presence in the dermatology sector.
YTD Price Performance: 19.00%
Average Trading Volume: 140,518
Technical Sentiment Signal: Hold
Current Market Cap: €2.09B
See more insights into ALM stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue